Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2

OBJECTIVE: To evaluate the efficacy and safety of eptinezumab, a humanized anti–calcitonin gene-related peptide monoclonal antibody, in the preventive treatment of chronic migraine (CM). METHODS: The Prevention of Migraine via Intravenous ALD403 Safety and Efficacy–2 (PROMISE-2) study was a phase 3,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lipton, Richard B., Goadsby, Peter J., Smith, Jeff, Schaeffler, Barbara A., Biondi, David M., Hirman, Joe, Pederson, Susan, Allan, Brent, Cady, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274916/
https://www.ncbi.nlm.nih.gov/pubmed/32209650
http://dx.doi.org/10.1212/WNL.0000000000009169

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7274916/
https://www.ncbi.nlm.nih.gov/pubmed/32209650
http://dx.doi.org/10.1212/WNL.0000000000009169

Ejemplares similares